Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

SYP-5

🥰Excellent
Catalog No. T13050Cas No. 1384268-04-5

SYP-5 is a novel inhibitor of HIF-1, suppresses tumor cells invasion and angiogenesis.

SYP-5

SYP-5

🥰Excellent
Purity: 98.31%
Catalog No. T13050Cas No. 1384268-04-5
SYP-5 is a novel inhibitor of HIF-1, suppresses tumor cells invasion and angiogenesis.
Pack SizePriceAvailabilityQuantity
1 mg$30In Stock
5 mg$61In Stock
10 mg$101In Stock
25 mg$198In Stock
50 mg$318In Stock
100 mg$493In Stock
1 mL x 10 mM (in DMSO)$68In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "SYP-5"

Select Batch
Purity:98.31%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
SYP-5 is a novel inhibitor of HIF-1, suppresses tumor cells invasion and angiogenesis.
In vitro
A novel HIF-1 inhibitor SYP-5 was first observed by the luciferase reporter assay. Western blots results showed SYP-5 inhibited hypoxia-induced upregulation of HIF-1. Moreover, the proteins of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMP)-2 that are targets of HIF-1, were down-regulated by SYP-5. Furthermore, in the tube formation assay, SYP-5 suppressed angiogenesis induced by hypoxia and VEGF in vitro. Additionally, using Transwell and RTCA assays, we found that SYP-5 also retarded the Hep3B and Bcap37 cells migration and invasion induced by hypoxia and FBS. Detected the upstream pathways related to HIF-1 and found both PI3K/AKT and MAPK/ERK were involved in the SYP-5 mediated invasive inhibition of Bcap37 cells. SYP-5 inhibits tumor cell migration and invasion, as well as tumor angiogenesis, which are mediated by suppressing PI3K/AKT- and MAPK/ERK-dependent HIF-1 pathway. It suggests that SYP-5 might be a potential HIF-1 inhibitor as an anticancer agent.
Chemical Properties
Molecular Weight312.38
FormulaC18H16O3S
Cas No.1384268-04-5
SmilesCC1(C)Oc2ccc(C(=O)\C=C\c3cccs3)c(O)c2C=C1
Relative Density.1.263 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 33.33 mg/mL (106.70 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.2012 mL16.0061 mL32.0123 mL160.0615 mL
5 mM0.6402 mL3.2012 mL6.4025 mL32.0123 mL
10 mM0.3201 mL1.6006 mL3.2012 mL16.0061 mL
20 mM0.1601 mL0.8003 mL1.6006 mL8.0031 mL
50 mM0.0640 mL0.3201 mL0.6402 mL3.2012 mL
100 mM0.0320 mL0.1601 mL0.3201 mL1.6006 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy SYP-5 | purchase SYP-5 | SYP-5 cost | order SYP-5 | SYP-5 chemical structure | SYP-5 in vitro | SYP-5 formula | SYP-5 molecular weight